Literature DB >> 27252852

Pulmonary arterial hypertension in primary amyloidosis.

Meghan M Cirulis1, Lyska L Emerson2, David A Bull3, Nathan Hatton4, Jose Nativi-Nicolai5, Gerhard C Hildebrandt6, John J Ryan5.   

Abstract

Amyloidosis involves extravascular deposition of fibrillar proteins within tissues and organs. Primary light chain amyloidosis represents the most common form of systemic amyloidosis involving deposition of monoclonal immunoglobulin light chains. Although pulmonary amyloid deposition is common in primary amyloidosis, clinically significant pulmonary amyloidosis is uncommon, and elevated pulmonary artery pressures are rarely observed in the absence of other underlying etiologies for pulmonary hypertension, such as elevated filling pressures secondary to cardiac amyloid. In this case report, we present a patient with primary light chain amyloidosis and pulmonary arterial hypertension in the setting of pulmonary vascular and right ventricular myocardial amyloid deposition.

Entities:  

Keywords:  Congo red stain; medial hypertrophy; multiple myeloma; pulmonary vascular disease

Year:  2016        PMID: 27252852      PMCID: PMC4869930          DOI: 10.1086/686172

Source DB:  PubMed          Journal:  Pulm Circ        ISSN: 2045-8932            Impact factor:   3.017


  20 in total

1.  Reversible pulmonary hypertension and thalidomide therapy for multiple myeloma.

Authors:  Tallal Hussein Younis; Arif Alam; Pamela Paplham; Edward Spangenthal; Philip McCarthy
Journal:  Br J Haematol       Date:  2003-04       Impact factor: 6.998

Review 2.  Pulmonary hypertension in autoimmune rheumatic diseases: where are we now?

Authors:  M Magliano; D A Isenberg; J Hillson
Journal:  Arthritis Rheum       Date:  2002-08

Review 3.  Lung disease in rheumatoid arthritis.

Authors:  Zulma X Yunt; Joshua J Solomon
Journal:  Rheum Dis Clin North Am       Date:  2015-02-03       Impact factor: 2.670

Review 4.  Diagnosis and management of the cardiac amyloidoses.

Authors:  Rodney H Falk
Journal:  Circulation       Date:  2005-09-27       Impact factor: 29.690

5.  Pulmonary hypertension related to thalidomide therapy in refractory multiple myeloma.

Authors:  E Antonioli; C Nozzoli; G Gianfaldoni; F Mannelli; S Rossi; S Betti; P Bernardeschi; G Fiorentini; A Bosi
Journal:  Ann Oncol       Date:  2005-07-12       Impact factor: 32.976

Review 6.  Rheumatoid arthritis-associated lung disease.

Authors:  Megan Shaw; Bridget F Collins; Lawrence A Ho; Ganesh Raghu
Journal:  Eur Respir Rev       Date:  2015-03

7.  Pulmonary hypertension in patients with amyloidosis.

Authors:  D Dingli; J P Utz; M A Gertz
Journal:  Chest       Date:  2001-11       Impact factor: 9.410

8.  Pulmonary hypertension from prominent vascular involvement in diffuse amyloidosis.

Authors:  S T Shiue; D P McNally
Journal:  Arch Intern Med       Date:  1988-03

Review 9.  Pulmonary hypertension in systemic autoimmune disease.

Authors:  I Gurubhagavatula; H I Palevsky
Journal:  Rheum Dis Clin North Am       Date:  1997-05       Impact factor: 2.670

10.  Mechanism of the susceptibility of remodeled pulmonary vessels to drug-induced cell killing.

Authors:  Yasmine F Ibrahim; Chi-Ming Wong; Ludmila Pavlickova; Lingling Liu; Lobsang Trasar; Geetanjali Bansal; Yuichiro J Suzuki
Journal:  J Am Heart Assoc       Date:  2014-02-26       Impact factor: 5.501

View more
  2 in total

1.  Pulmonary amyloidosis as the presenting finding in a patient with multiple myeloma.

Authors:  Ryan Kronen; David R Ziehr; Ashley E D Kane; Paul A VanderLaan; Cyrus A Kholdani; Robert W Hallowell
Journal:  Respir Med Case Rep       Date:  2022-03-18

2.  A preliminary study of the effect of a high-salt diet on transcriptome dynamics in rat hypothalamic forebrain and brainstem cardiovascular control centers.

Authors:  Chitra Devi Ramachandran; See Ziau Hoe; Khadijeh Gholami; Sau Kuen Lam
Journal:  PeerJ       Date:  2020-03-03       Impact factor: 2.984

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.